Introduction
Shigella flexneri, a gram-negative enterobacterium, is the etiological agent of bacillary dysentery. It causes disease by invading the epithelial layer and the lamina propria of the colon, generating a very severe inflammation (1) . Shigella invades the colon by translocating through M cells (2) from the lumen of the intestine directly into lymphoid follicles and subsequently to the submucosa. Once in the lymphoid follicles and in the lamina propria, shigella infects tissue macrophages. We have recently shown that invasive strains of shigella induce macrophage apoptosis (3). Here we address the question whether S. flexneri-infected macrophages that are undergoing apoptosis can liberate cytokines capable of mediating an inflammatory process.
Macrophages produce, in response to a variety of stimuli, three proinflammatory cytokines: IL-1, IL-6, and TNFa. IL-6 and TNFa are secreted soon after synthesis. In contrast, both the precursor forms of IL-la and IL-i /3 are accumulated in the cell's cytosol (4) . Their proteolytically processed forms are found in culture supernatants, but not intracellularly. Since IL-1 does not have a signal peptide and is not secreted via a classical pathway, it has been suggested that this cytokine is released during apoptosis (5) .
Colonic macrophages contain IL-1 (6) (7) (8) . As a model system to study the release of cytokines after S. flexneri infection, we used LPS-stimulated murine peritoneal macrophages, which contain pools of IL-1. We showed that stimulated peritoneal macrophages infected with wild-type S. flexneri, but not with a noninvasive derivative, release large amounts of IL-1, but not IL-6 or TNFa. Both IL-la and IL-1# are liberated, but only IL-1,/ is released in its mature form. We also demonstrated that wild-type shigella cannot induce the de novo production of cytokines and can only release presynthesized IL-I. Our results indicate that macrophage apoptosis is likely to play an essential physiological role in the course of shigellosis, namely signaling the onset of inflammation.
Methods
Bacteria. The wild-type serotype 5 S. flexneri strain M9OT and its plasmid-cured, noninvasive, noncytotoxic derivative BS176 were previously described (3 macrophage culture supernatants were incubated with the anti-murine IL-la and LL-I,6 antibodies (British Biotechnology, Abingdon, UK) for 1 h before addition to the thymocyte culture at the indicated concentrations.
IL-6 bioassay. IL-6 activity was determined using the specific 7TD1 IL-6-dependent cell line as described (10) . In brief, cells were cultured in RPMI-1640 medium supplemented with antibiotics, 2-mercaptoethanol (5 x 10-5M), and 10% FCS in the presence of serial dilutions of culture supernatants. After 4 d of culture, the cell proliferation was monitored using the 3(4,5-dimethyl-thiazoyl-2-yl)2,5 diphenyltetrazolium salt (MTT) dye method salts and measured with a microELISA automated reader at 540 nm. 1 U of 1L-6 corresponds to the halfmaximum growth of 7TD1 cells.
TNFa bioassay. Essentially as described in (11) (experimental release -spontaneous release)/(total release -spontaneous release). Spontaneous release was defined as the LDH activity in supernatants of macrophages incubated in medium alone, while LDH activity from macrophage lysates was defined as total release. S. flexneri strains have no colorimetric activity by themselves in this assay.
Antibodies, immnunoblot analysis and ELISA. Macrophage cell lysates or culture supernatant equivalent to 2 x 104 cells were resolved in SDS-PAGE, transferred to nitrocellulose and incubated with antimurine IL-la or 1L-1/3 polyclonal antibodies (British Biotechnology, UK) at a 1:100 dilution. After washing, the blots were further incubated with alkaline phosphatase-labeled secondary antibodies (Nordic Immunology, Tilburg, The Netherlands), revealed with the Western blotting detection kit ECL (Amersham Life Sciences, Amersham, UK), and exposed to X-Omat x-ray films.
IL-la was quantified with the Intertest-lax mouse ELISA Kit (Genzyme Corp., Cambridge MA). IL-6 and TNFa were assayed with the appropriate murine ELISA kit (Endogen Inc., Boston MA).
Results
IL-1 release was assayed during S. flexneri-induced apoptosis. Peritoneal macrophages were stimulated for 18 h with purified E. coli LPS, washed, and infected with either the cytotoxic S. flexneri strain M9OT or its noncytotoxic, plasmidless derivative BS176. The culture supernatants were assayed for IL-1 bioactivity, as described in Methods.
As early as 15 min after infection of LPS-stimulated macro- IL-6 (12) and TNFa (13) have been reported to be able to promote thymocyte proliferation under the conditions described for the IL-i bioassay. In order to determine whether the activity detected was in fact due to IL-1, the supernatant of M9OT-infected macrophages was preincubated with both anti-murine IL-la (3 yg/ml final concentration) and IL-1,6 (30 jig/ml final concentration) antibodies. The antibodies inhibited thymocyte proliferation by more than 85%. These same antibodies did not significantly inhibit the biological activity of a mixture of human recombinant IL-la and IL-1,B, demonstrating the specificity of the antibodies used.
The release of IL-1 activity by macrophages infected with M9OT wild-type strain of S. flexneri, reached its half-maximal value around 45 min postinfection (Fig. 1 A) . The total amount of IL-la in the pooled supernatants of cells infected with wildtype shigella in the experiment reported above was 8.1 ng/ml measured in an ELISA. There were 9.3 ng/ml of IL-la in the cells before the infection, as assayed in freezed and thawed cultures. Thus, 87% of the IL-la present in the cells was released after infection with wild-type shigella. Macrophages infected with the plasmid-cured derivative strain BS176 did not release significant amounts of IL-1 activity (Fig. 1 A) .
When IL-la was measured antigenically (Fig. 1 B) , the half-maxil release was attained between 30 and 45 min postinfection, earlier than the release of IL-1 activity. The delay in the release of IL-l activity, relative to the relapse of IL-i antigen, might reflect either a difference in the sensitivity of the methodology or a time-dependent conversion of IL-if3 from its biologically inactive to its mature form. The cytotoxic strain M9OT killed around 50% of peritoneal macrophages after 60 min of infection (Fig. 1 C) . Neither the plasmidless strain BS176 (Fig. 1 C) , nor purified E. coli LPS (data not shown), were cytotoxic for peritoneal macrophages.
The slopes of curves fitted to the measurements of IL-i during the first 60 min postinfection with M9OT ( Fig. 1) are: 1.3 for the antigenically detected IL-la, 1.1 for the IL-1 biological activity, and 0.7 for cytotoxicity measured by LDH release. The relative rates of IL-la and LDH release were analyzed with a paired t test and they show a significant difference at P < .025, indicating that IL-1 release is slightly faster than that of LDH. These results suggest that apoptotic macrophages do not release IL-1 via a passive leakage of the cytokine.
When Western immunoblots were incubated with either anti-IL-la (Fig. 2 A) or anti-IL-lf antibodies (Fig. 2 B) , the precursor form of both IL-la and IL-1p were present in cell lysates of LPS-stimulated peritoneal macrophage (Fig. 2 A, lane 2 and Fig. 2 B, lane 2) but not in nonstimulated macrophages (Fig. 2 A, lane I and Fig. 2 B, lane 1) . Only the precursor form of IL-la ( Fig. 2 A, lane 3) , and both the precursor and the mature form of IL-1, (Fig. 2 B, lane 3) were detected in the culture supernatant of peritoneal macrophages infected with the cytotoxic strain M9OT. Neither IL-la nor IL-l/3 were detected in culture supernatants of macrophages infected with the noncytotoxic strain BS176 (Fig. 2 A, lane 4 and Fig. 2 B, lane 4) . Thus, S. flexneri infection provokes the release of the biologically active precursor form of IL-la and cleaved IL-1,6. In order to establish whether apoptosis induced by S. flexneri can promote the secretion of IL-6 and TNFa, we tested the culture supernatants of LPS-stimulated and shigella-infected macrophages for the presence of these cytokines. The supernatants of cells 60 to 120 min after infection were measured in an ELISA, and the results are shown in Table I . The release of IL-6 by M9OT-infected cells did not exceed that of cells incubated in medium alone, where the remaining IL-6 is consecutive to the LPS pretreatment. As expected, macrophages either infected with the noncytotoxic strain BS176, or restimulated with purified E. coli LPS, secreted IL-6. The amount of released TNFa was low (< 200 pg/ml) under all conditions wherein macrophages were preincubated with LPS. When macrophages were not prestimulated with LPS, infection with M9OT resulted in very modest (< 600 pg/ml) TNFa release. In contrast, cells infected with BS176 or stimulated with LPS released larger amounts of TNFa (> 1000 pg/ml) ( Table I) . Taken together, these results indicate that LPS-stimulated macrophages are incapable of de novo cytokine synthesis, and reflect the results described for IL-6. Comparable results were obtained with respect to IL-6 and TNFa activities throughout the time course of infection (data not shown).
We confirmed that infection with shigella induces the release of presynthesized IL-1 and not the de novo expression of the cytokine by comparing the release of IL-1 in macrophages that were incubated for 18 h in the presence or in the absence of We have recently shown that cytotoxic strains of S. flexneri induce apoptosis in both peritoneal macrophages and in the macrophage-like cell line J774 (3). We decided to investigate the relationship between the induction of macrophage apoptosis by shigella and the initiation of inflammation during shigella infections. Here, we describe that the wild-type strain of S. flexneri induces a rapid and significant release of IL-I as measured antigenically as well as biologically (Fig. 1) . The noncytotoxic strain of shigella or purified LPS are incapable of stimulating this release.
IL-I is released with slightly but significantly faster kinetics than LDH after a S. flexneri infection, suggesting that IL-I release during S. flexneri-induced apoptosis is not a secondary effect of cell injury despite the cytoplasmic localization of both LDH and the precursor forms of IL-i.
Both forms of IL-i are synthesized as polypeptides of 31 kD and processed through a specific proteolytic cleavage into molecules of 17.5 kD. Both the precursor and the mature ILla, but only the mature IL-6 are biologically active (4). We tested which forms of IL-la and IL-/I are released during S.
flexneri-induced apoptosis. Only the precursor form of IL-la and both forms of IL-1,6 are present in infected macrophage supernatants. This suggests that IL-lIB converting enzyme activity (ICE)' (14, 15) was available in this context, while pro-IL-la processing enzymes were not (16) . Taking together the comparison in the kinetics of IL-i and LDH release, as well as the cleavage of IL-1i/, it appears that the cytokine release is specific and not due to passive leakage.
Macrophages undergoing apoptosis after wild-type S. flexneri infection release relatively low amounts of IL-6 or TNFa (Table I) , probably because release of these two cytokines requires de novo synthesis and the biosynthetic machinery of an apoptotic cell is seriously compromised. Furthermore, the difference in the TNFa response in macrophages that were preincubated for 18 h in the presence or absence of LPS and then restimulated with LPS (Table I) indicate that after LPSstimulation macrophages were in a state of anergy (17, 18) . This implies that in the paradigm described here infected macrophages cannot effectively synthesize cytokines.
The experiments in Table II show that nonstimulated, naive macrophages, in contrast to stimulated macrophages, do not release IL-1 after shigella infections. These data indicate again that S. flexneri cannot induce the production of the cytokine; only its release. Taken together, the experiments described above suggest that wild-type shigella cannot induce the biosynthesis of cytokines in macrophages.
Hogquist et al. (5) reported that ATP-or cytotoxic T cell (CTL) -induced apoptosis of peritoneal macrophages is accompanied by release of mature IL-ia and IL-I13. In their study, both cell death and IL-1 release was detected around 6 h after the induction of apoptosis. The discrepancy between this report and that of Hogquist et al., regarding the maturation of IL-ia, might reflect the difference in the kinetics or in the availability of IL-ia converting enzymes between different pathways of induction of apoptosis. The mechanisms by which apoptotic macrophages process and release IL-i awaits characterization and may illustrate a pathway for the release of other cytokines that do not contain a signal sequence.
It is interesting to speculate whether apoptosis and IL-1 release are two dissociable events in S. flexneri infection. This seems unlikely since apoptosis induced by bacteria or by other effectors (5, 19) Indeed, it is now well established that colonic macrophages are activated (22, 23) and express IL-i (6, 7), specifically IL-13 (8) , probably as a result of exposure to LPS from enteric bacteria.
The importance of apoptosis in the pathogenicity of different infectious diseases is being increasingly recognized (24) . The induction of macrophage apoptosis by bacterial pathogens like S. flexneri and Bordetella pertussis (25) are now well established. Our results may have important biological implications since the bacterial induction of apoptosis and the subsequent release of presynthesized IL-1 might serve a pivotal role in the onset of inflammation. Thus, IL-1 would be a distress signal released by macrophages just before cell death by apoptosis.
